GoodRx could seek up to $969M in IPO
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
Report: GoodRx files for IPO
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.